Table 2.
Cancer vaccines in Phase I/II based on tumor-specific antigens (TSAs).
| Tumor | Status | Phases | NCT Number |
|---|---|---|---|
| ALL | Active, not recruiting | Phase 1|Phase 2 | NCT03559413 |
| Breast Cancer | Recruiting | Phase 1 | NCT04105582 |
| Fibrolamellar HCC | Recruiting | Phase 1 | NCT04248569 |
| Follicular Lymphoma | Not yet recruiting | Phase 1 | NCT03361852 |
| Gastric Cancers | Recruiting | Not Applicable | NCT03468244 |
| Glioblastoma | Recruiting | Phase 1 | NCT04015700 |
| Active, not recruiting | Phase 1 | NCT03422094 | |
| Recruiting | Phase 1 | NCT02287428 | |
| Completed | Phase 1 | NCT02149225 | |
| HCC | Recruiting | Phase 1|Phase 2 | NCT04251117 |
| Recruiting | Phase 1 | NCT03674073 | |
| Kidney Cancer | Recruiting | Phase 1 | NCT02950766 |
| Lymphocytic Leukemia | Not yet recruiting | Phase 1 | NCT03219450 |
| Melanoma | Not yet recruiting | Phase 1|Phase 2 | NCT04364230 |
| Recruiting | Phase 1 | NCT04072900 | |
| Not yet recruiting | Phase 1 | NCT03929029 | |
| Active, not recruiting | Phase 2 | NCT02129075 | |
| Completed | Phase 1 | NCT02035956 | |
| Active, not recruiting | Phase 1 | NCT01970358 | |
| Multiple Cancers | Recruiting | Phase 1 | NCT04147078 |
| Recruiting | Phase 1 | NCT03956056 | |
| Recruiting | Phase 1|Phase 2 | NCT03953235 | |
| Not yet recruiting | Not Applicable | NCT03908671 | |
| Active, not recruiting | Phase 1 | NCT03662815 | |
| Recruiting | Phase 1|Phase 2 | NCT03639714 | |
| Recruiting | Phase 1 | NCT03568058 | |
| Recruiting | Phase 1 | NCT04087252 | |
| Recruiting | Phase 1 | NCT03552718 | |
| NSCLC | Recruiting | Phase 1 | NCT04078269 |
| Not yet recruiting | Phase 1 | NCT03871205 | |
| Recruiting | Phase 1 | NCT04487093 | |
| Recruiting | Phase 1 | NCT04397926 | |
| Ovarian Cancer | Not yet recruiting | Phase 1 | NCT04024878 |
| Pancreatic Cancer | Recruiting | Phase 1 | NCT04161755 |
| Recruiting | Phase 1 | NCT03645148 | |
| Active, not recruiting | Phase 1 | NCT03122106 | |
| Recruiting | Phase 1 | NCT03558945 | |
| Pediatric Brain Tumor | Not yet recruiting | Phase 1 | NCT03988283 |
| Not yet recruiting | Phase 1 | NCT03068832 | |
| Prostate Cancer | Recruiting | Phase 1 | NCT03532217 |
| SCLC/NSCLC | Not yet recruiting | Phase 2 | NCT04397003 |
| Not yet recruiting | Phase 1 | NCT04266730 | |
| SPCM | Recruiting | Early Phase 1 | NCT03631043 |
| TNBC | Recruiting | Phase 1 | NCT03199040 |
| UBC | Recruiting | Phase 1 | NCT03359239 |
ALL, acute lymphoblastic leukemia; HCC, hepatocellular carcinoma; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; SPCM, smoldering plasma cell myeloma; TNBC, triple-negative breast carcinoma; UBC, urothelial/bladder cancer.